1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ARTIFICIAL INTELLIGENCE (AI) IN THE DRUG DISCOVERY MARKET, BY OFFERING
5.1. Introduction
5.2. Software
5.3. Services
6. ARTIFICIAL INTELLIGENCE (AI) IN THE DRUG DISCOVERY MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Machine Learning
6.3. Deep Learning
6.4. Natural Language Processing (NLP)
6.5. Other AI Technologies
7. ARTIFICIAL INTELLIGENCE (AI) IN THE DRUG DISCOVERY MARKET BY THERAPEUTIC AREA
7.1. Introduction
7.2. Oncology
7.3. Neurology
7.4. Cardiovascular Diseases
7.5. Infectious Diseases
7.6. Others
8. ARTIFICIAL INTELLIGENCE (AI) IN THE DRUG DISCOVERY MARKET BY APPLICATION
8.1. Introduction
8.2. Target Identification and Validation
8.3. Hit-to-Lead Identification
8.4. Lead Optimization
8.5. Drug Repurposing
8.6. Others
9. ARTIFICIAL INTELLIGENCE (AI) IN THE DRUG DISCOVERY MARKET BY END-USER
9.1. Introduction
9.2. Pharmaceutical Companies
9.3. Biotechnology Companies
9.4. Contract Research Organizations (CROs)
9.5. Research Institutes
9.6. Others
10. ARTIFICIAL INTELLIGENCE (AI) IN THE DRUG DISCOVERY MARKET BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. United States
10.2.2. Canada
10.2.3. Mexico
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Others
10.4. Europe
10.4.1. United Kingdom
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Others
10.5. Middle East and Africa
10.5.1. Saudi Arabia
10.5.2. UAE
10.5.3. Others
10.6. Asia Pacific
10.6.1. Japan
10.6.2. China
10.6.3. India
10.6.4. South Korea
10.6.5. Indonesia
10.6.6. Taiwan
10.6.7. Others
11. COMPETITIVE ENVIRONMENT AND ANALYSIS
11.1. Major Players and Strategy Analysis
11.2. Market Share Analysis
11.3. Mergers, Acquisitions, Agreements, and Collaborations
12. COMPANY PROFILES
12.1. IBM Corporation
12.2. Microsoft Corporation
12.3. Alphabet Inc. (Google)
12.4. NVIDIA Corporation
12.5. Atomwise, Inc.
12.6. BenevolentAI
12.7. Exscientia Ltd.
12.8. Insilico Medicine
12.9. Cyclica Inc.
12.10. Cloud Pharmaceuticals, Inc.